XML 21 R12.htm IDEA: XBRL DOCUMENT
v3.22.2

Restructuring, Strategic Transaction and Integration (Notes) | 6 Months Ended
--- | ---
Jun. 30, 2022
Restructuring and Related Activities [Abstract] |
Restructuring and Related Activities Disclosure | Restructuring, Strategic Transaction and Integration Restructuring, strategic transaction and integration expenses were $13.5 million and $3.8 million for the three months ended June 30, 2022 and 2021, respectively, and $47.4 million and $6.6 million for six months ended June 30, 2022 and 2021, respectively. Restructuring During the three and six months ended June 30, 2022, restructuring charges were $1.7 million and $4.9 million, respectively, and were related to severance costs. Restructuring charges during the three and six months ended June 30, 2021 were not material. The following table summarizes the activity in our restructuring-related accrual by major type of cost for the period ended June 30, 2022 (in thousands):
|  | Severance Pay and Benefits |  |  |  | Retention and Facility Closure Costs |  | Total
Accrued balance, January 1, 2022 |  | $ | 499 |  |  |  |  | $ | 165 |  |  | $ | 664 |
Acquired restructuring liabilities |  | 5,796 |  |  |  |  | 1,740 |  |  | 7,536 |
Charges incurred |  | 3,222 |  |  |  |  | — |  |  | 3,222 |
Payments |  | (2,030) |  |  |  |  | — |  |  | (2,030) |
Currency translation |  | (147) |  |  |  |  | (40) |  |  | (187) |
Accrued balance, March 31, 2022 |  | $ | 7,340 |  |  |  |  | $ | 1,865 |  |  | $ | 9,205 |
Charges incurred |  | 1,710 |  |  |  |  | — |  |  | 1,710 |
Payments |  | (3,352) |  |  |  |  | (212) |  |  | (3,564) |
Currency translation |  | (256) |  |  |  |  | (94) |  |  | (350) |
Other adjustments |  | (38) |  |  |  |  | — |  |  | (38) |
Accrued balance, June 30, 2022 |  | $ | 5,404 |  |  |  |  | $ | 1,559 |  |  | $ | 6,963 |
Strategic Transaction and Integration Expenses We incurred and expensed $11.8 million and $3.7 million in strategic transaction and integration expenses during the three months ended June 30, 2022 and 2021, respectively, and we incurred and expensed $42.5 million and $6.5 million in strategic transaction and integration expenses during the six months ended June 30, 2022 and 2021, respectively, which are included in restructuring, strategic transaction and integration expenses in our condensed consolidated statements of operations. The strategic transaction and integration expenses during the three and six months ended June 30, 2022 were primarily related to transaction and integration expenses associated with our acquisition of Smiths Medical on January 6, 2022 (see Note 3: Acquisitions) which primarily included legal expenses, bank fees and employee costs. The six months ended June 30, 2022 also included a United Kingdom stamp tax. The strategic transaction and integration expenses for the three and six months ended June 30, 2021 were primarily related to integration costs associated with acquisitions, the Hospira Infusion Systems ("HIS") earn-out dispute with Pfizer and one-time costs incurred to comply with regulatory initiatives.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for restructuring and related activities. Description of restructuring activities such as exit and disposal activities, include facts and circumstances leading to the plan, the expected plan completion date, the major types of costs associated with the plan activities, total expected costs, the accrual balance at the end of the period, and the periods over which the remaining accrual will be settled. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 5.P.4(e)) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -URI http://asc.fasb.org/topic&trid=2175745 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration